It is a trading private limited company based in Nagpur, Maharashtra, India, established in 2010.
2010 | Nagpur, Maharashtra, India | ActiveMacknoll Pharmaceuticals Private Limited, a active private limited company, was established on 23 July 2010 in Nagpur, Maharashtra, India. Engaging in wholesale within the trade sector, it holds CIN: U24239MH2010PTC205875. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Salman Ismail Bloch (Director), Sakib Sandhi (Director). Past directors included Sunil Pyarelal Zalpure, Sureshkumar Mohanlal Prajapati, Mohammed Idrish Yusufbhai Shaikh. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Plot No. 19, Shrikrishna Nagar, Wathoda Road, Nagpur, Maharashtra, 440008.
U24239MH2010PTC205875
205875
23 July 2010
₹0.10 M
₹0.10 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Macknoll Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Salman Ismail Bloch | Director | 14 Mar 2025 | Current |
| Sakib Sandhi | Director | 14 Mar 2025 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 26 Aug 2019 | Past |
| Pramod Abcsdd | Director | 21 Mar 2025 | Past |
| Pramod Abcsdd | Director | 21 Mar 2025 | Past |
| Pramod Abcsdd | Director | 25 Jul 2024 | Past |
| Pramod Abcsdd | Director | 25 Jul 2024 | Past |
| Pramod Abcsdd | Director | 25 Jul 2024 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Macknoll Pharmaceuticals Private Limited, for the financial year ended 2017, experienced significant growth in revenue, with a 32.01% increase. The company also saw a substantial improvement in profitability, with a 144.65% increase in profit. The company's net worth Soared by an impressive increase of 92.37%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2017, Macknoll Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Macknoll Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Macknoll Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Macknoll Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Salman Ismail Bloch was appointed as a Director was appointed as a Director on 14 Mar 2025 & has been associated with this company since 10 months 6 days . was completed.
Sakib Sandhi was appointed as a Director was appointed as a Director on 14 Mar 2025 & has been associated with this company since 10 months 6 days . was recorded as a recent event.
Progress on Macknoll Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Macknoll Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was recorded as a recent event.
Progress on Macknoll Pharmaceuticals Private Limited was registered on 23 Jul 2010 with Roc Mumbai & aged 15 years 5 months as per MCA records. was documented.
The CIN of Macknoll Pharmaceuticals Private Limited is U24239MH2010PTC205875.
Macknoll Pharmaceuticals Private Limited is headquartered at Plot No. 19, Shrikrishna Nagar, Wathoda Road, Nagpur, Maharashtra, 440008.
Macknoll Pharmaceuticals Private Limited was incorporated on 23 July 2010.
The current directors of Macknoll Pharmaceuticals Private Limited are
The primary industry of Macknoll Pharmaceuticals Private Limited is Trade.
Macknoll Pharmaceuticals Private Limited is unlisted.
The authorized capital of Macknoll Pharmaceuticals Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
The compliance status of Macknoll Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX